Jove
Visualize
Contact Us

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From stones to system: integrating kidney stones disease into the cardiovascular-kidney-metabolic continuum.

Current opinion in nephrology and hypertension·2026
Same author

Vitamin D in Chronic Kidney Disease: Familiar Treatment, Unresolved Questions.

American journal of nephrology·2025
Same author

Acute Effect of High Fat Intake on Urinary Acidification Parameters.

Kidney international reports·2025
Same author

SGLT-2 inhibitors for the prevention of recurrent nephrolithiasis.

BMJ (Clinical research ed.)·2024
Same author

Fat Distribution and Urolithiasis Risk Parameters in Uric Acid Stone Formers and Patients with Type 2 Diabetes Mellitus.

Clinical journal of the American Society of Nephrology : CJASN·2024
Same author

Gaps in kidney stone disease management: From clinical theory to patient reality.

Urolithiasis·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 21, 2026

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

Post-renal transplantation hypophosphatemia.

Khashayar Sakhaee1

  • 1Department of Internal Medicine, Charles & Jane Pak Center for Mineral Metabolism & Clinical Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8885, USA. Khashayar.sakhaee@utsouthwestern.edu

Pediatric Nephrology (Berlin, Germany)
|July 16, 2009
PubMed
Summary

Post-renal transplant bone disease is linked to persistent kidney phosphorus wasting. This review explores the causes and challenges in diagnosing this condition, highlighting its clinical significance.

More Related Videos

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
06:23

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

Related Experiment Videos

Last Updated: Jun 21, 2026

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
06:23

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Bone disease is common after solid organ transplantation.
  • Post-renal transplant (PRT) subjects exhibit a persistently high fracture rate compared to other transplant recipients.
  • Persistent renal phosphorus (Pi) wasting is a key pathophysiologic difference in PRT bone disease.

Purpose of the Study:

  • To review the pathophysiology of post-renal transplant bone disease.
  • To explore the role of novel phosphaturic agents and parathyroid hormone (PTH) in PRT hypophosphatemia.
  • To discuss diagnostic challenges of PRT bone disease in adults and pediatrics.

Main Methods:

  • Literature review of pathophysiologic mechanisms.
  • Analysis of factors contributing to negative Pi balance.
  • Discussion of clinical presentation and diagnostic difficulties.

Main Results:

  • PRT bone disease is characterized by persistent renal Pi wasting.
  • Novel phosphaturic agents may contribute to bone disease development.
  • The interplay between Pi wasting and PTH in PRT bone disease requires further investigation.

Conclusions:

  • Persistent renal Pi wasting is a significant factor in PRT bone disease.
  • Accurate diagnosis of PRT bone disease phenotypes is challenging.
  • Further research is needed to elucidate the exact mechanisms and improve diagnostic strategies.